Interleukin-22 modulates cisplatin sensitivity of osteosarcoma cells by regulating the STAT3 signaling pathway

The present study aimed to investigate the regulatory mechanisms by which interleukin (IL)-22 regulates cisplatin (DDP) sensitivity in osteosarcoma cells. Firstly, reverse transcription-quantitative (RT-q) PCR and western blotting demonstrated that IL-22 expression was significantly increased in ost...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhiqiang, Xu, Renjie, Zhang, Xiangxin, Shen, Jun, Chen, Guangxiang, Zou, Tianming, Yu, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966104/
https://www.ncbi.nlm.nih.gov/pubmed/32010312
http://dx.doi.org/10.3892/etm.2019.8352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966104/
https://www.ncbi.nlm.nih.gov/pubmed/32010312
http://dx.doi.org/10.3892/etm.2019.8352

Ejemplares similares